View ValuationGanesh Benzoplast 将来の成長Future 基準チェック /06現在、 Ganesh Benzoplastの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長17.9%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹112, the stock trades at a trailing P/E ratio of 11x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 26% over the past three years.分析記事 • Jun 04Ganesh Benzoplast's (NSE:GANESHBE) Earnings Are Weaker Than They SeemGanesh Benzoplast Limited ( NSE:GANESHBE ) announced strong profits, but the stock was stagnant. We did some digging...Reported Earnings • May 28Full year 2026 earnings released: EPS: ₹10.19 (vs ₹5.29 in FY 2025)Full year 2026 results: EPS: ₹10.19 (up from ₹5.29 in FY 2025). Revenue: ₹4.37b (up 17% from FY 2025). Net income: ₹733.4m (up 93% from FY 2025). Profit margin: 17% (up from 10% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 14% per year.お知らせ • May 18Ganesh Benzoplast Limited to Report Q4, 2026 Results on May 27, 2026Ganesh Benzoplast Limited announced that they will report Q4, 2026 results on May 27, 2026Board Change • May 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. Non-Executive Independent Woman Director Amruta Thali was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Apr 10Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹92.23, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 47% over the past three years.Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: ₹2.24 (vs ₹2.55 in 3Q 2025)Third quarter 2026 results: EPS: ₹2.24 (down from ₹2.55 in 3Q 2025). Revenue: ₹1.13b (up 27% from 3Q 2025). Net income: ₹161.5m (down 12% from 3Q 2025). Profit margin: 14% (down from 21% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹80.46, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 46% over the past three years.Buy Or Sell Opportunity • Jan 27Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 18% to ₹70.48. The fair value is estimated to be ₹90.23, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 8.2%.分析記事 • Nov 21Some Investors May Be Willing To Look Past Ganesh Benzoplast's (NSE:GANESHBE) Soft EarningsSoft earnings didn't appear to concern Ganesh Benzoplast Limited's ( NSE:GANESHBE ) shareholders over the last week...Reported Earnings • Nov 19Second quarter 2026 earnings released: EPS: ₹3.30 (vs ₹2.29 in 2Q 2025)Second quarter 2026 results: EPS: ₹3.30 (up from ₹2.29 in 2Q 2025). Revenue: ₹990.0m (up 1.4% from 2Q 2025). Net income: ₹237.6m (up 44% from 2Q 2025). Profit margin: 24% (up from 17% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.お知らせ • Sep 26Ganesh Benzoplast Limited Appoints Amruta Pankaj Thali as Independent Woman DirectorGanesh Benzoplast Limited in its Annual General Meeting held on September 25, 2025 approved to appoint Ms. Amruta Pankaj Thali (DIN:11230644) as an Independent Woman Director of the Company.お知らせ • Sep 01+ 1 more updateGanesh Benzoplast Limited to Report Q3, 2026 Results on Feb 14, 2026Ganesh Benzoplast Limited announced that they will report Q3, 2026 results on Feb 14, 2026Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹2.52 (vs ₹2.28 in 1Q 2025)First quarter 2026 results: EPS: ₹2.52 (up from ₹2.28 in 1Q 2025). Revenue: ₹1.01b (up 15% from 1Q 2025). Net income: ₹181.3m (up 10% from 1Q 2025). Profit margin: 18% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 10% per year, which means it is performing significantly worse than earnings.お知らせ • Aug 11Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2025Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2025, at 11:00 Indian Standard Time.お知らせ • Aug 04Ganesh Benzoplast Limited to Report Q1, 2026 Results on Aug 11, 2025Ganesh Benzoplast Limited announced that they will report Q1, 2026 results on Aug 11, 2025Valuation Update With 7 Day Price Move • May 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹107, the stock trades at a trailing P/E ratio of 20.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 11% over the past three years.Reported Earnings • May 15Full year 2025 earnings released: EPS: ₹5.29 (vs ₹9.07 in FY 2024)Full year 2025 results: EPS: ₹5.29 (down from ₹9.07 in FY 2024). Revenue: ₹3.92b (down 18% from FY 2024). Net income: ₹380.9m (down 38% from FY 2024). Profit margin: 9.7% (down from 13% in FY 2024). Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 4% per year.お知らせ • May 10Ganesh Benzoplast Limited to Report Q4, 2025 Results on May 14, 2025Ganesh Benzoplast Limited announced that they will report Q4, 2025 results at 9:15 AM, Indian Standard Time on May 14, 2025New Risk • Apr 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹126, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 17% over the past three years.分析記事 • Mar 08A Piece Of The Puzzle Missing From Ganesh Benzoplast Limited's (NSE:GANESHBE) Share PriceWhen close to half the companies in India have price-to-earnings ratios (or "P/E's") above 26x, you may consider Ganesh...Valuation Update With 7 Day Price Move • Mar 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹127, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 29% over the past three years.Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹2.55 (vs ₹2.34 in 3Q 2024)Third quarter 2025 results: EPS: ₹2.55 (up from ₹2.34 in 3Q 2024). Revenue: ₹934.1m (down 12% from 3Q 2024). Net income: ₹183.9m (up 14% from 3Q 2024). Profit margin: 20% (up from 15% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 07Ganesh Benzoplast Limited to Report Q3, 2025 Results on Feb 12, 2025Ganesh Benzoplast Limited announced that they will report Q3, 2025 results on Feb 12, 2025New Risk • Jan 28New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.52b (US$98.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.分析記事 • Jan 21Some Investors May Be Worried About Ganesh Benzoplast's (NSE:GANESHBE) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? One...Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹145, the stock trades at a trailing P/E ratio of 16.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 52% over the past three years.Reported Earnings • Nov 15Second quarter 2025 earnings released: EPS: ₹2.29 (vs ₹2.33 in 2Q 2024)Second quarter 2025 results: EPS: ₹2.29. Revenue: ₹1.02b (flat on 2Q 2024). Net income: ₹164.6m (up 5.6% from 2Q 2024). Profit margin: 16% (in line with 2Q 2024).お知らせ • Nov 09Ganesh Benzoplast Limited to Report Q2, 2025 Results on Nov 14, 2024Ganesh Benzoplast Limited announced that they will report Q2, 2025 results on Nov 14, 2024お知らせ • Aug 13Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2024Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2024, at 11:00 Indian Standard Time.Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: ₹2.28 (vs ₹2.37 in 1Q 2024)First quarter 2025 results: EPS: ₹2.28. Revenue: ₹912.4m (down 25% from 1Q 2024). Net income: ₹164.3m (up 6.1% from 1Q 2024). Profit margin: 18% (up from 13% in 1Q 2024). The increase in margin was driven by lower expenses.お知らせ • Aug 03Ganesh Benzoplast Limited to Report Q1, 2025 Results on Aug 12, 2024Ganesh Benzoplast Limited announced that they will report Q1, 2025 results on Aug 12, 2024Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹160, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 4.5% over the past year.分析記事 • Jun 07Ganesh Benzoplast (NSE:GANESHBE) Strong Profits May Be Masking Some Underlying IssuesThe market shrugged off Ganesh Benzoplast Limited's ( NSE:GANESHBE ) solid earnings report. We did some digging and...分析記事 • Jun 05Take Care Before Diving Into The Deep End On Ganesh Benzoplast Limited (NSE:GANESHBE)With a price-to-earnings (or "P/E") ratio of 15.7x Ganesh Benzoplast Limited ( NSE:GANESHBE ) may be sending bullish...Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹9.07 (vs ₹8.73 in FY 2023)Full year 2024 results: EPS: ₹9.07 (up from ₹8.73 in FY 2023). Revenue: ₹4.91b (up 17% from FY 2023). Net income: ₹614.4m (up 12% from FY 2023). Profit margin: 13% (in line with FY 2023).お知らせ • May 23Ganesh Benzoplast Limited to Report Q4, 2024 Results on May 30, 2024Ganesh Benzoplast Limited announced that they will report Q4, 2024 results on May 30, 2024お知らせ • May 08Ganesh Benzoplast Limited Announces Resignation of Raunak Pilani as Non-Executive (Non-Independent) DirectorGanesh Benzoplast Limited informed that Mr. Raunak Pilani has tendered his resignation as a non-executive (non-independent) director of the Company with effect from May 6, 2024 and the Board has accepted his resignation vide circulatory resolution passed on May 07, 2024.お知らせ • Mar 01Ganesh Benzoplast Limited announced that it has received INR 324 million in fundingOn March 1, 2024, Ganesh Benzoplast Limited, closed the transaction.Reported Earnings • Feb 13Third quarter 2024 earnings released: EPS: ₹2.34 (vs ₹2.33 in 3Q 2023)Third quarter 2024 results: EPS: ₹2.34 (up from ₹2.33 in 3Q 2023). Revenue: ₹1.08b (up 8.9% from 3Q 2023). Net income: ₹160.8m (up 11% from 3Q 2023). Profit margin: 15% (in line with 3Q 2023).分析記事 • Feb 06Ganesh Benzoplast Limited (NSE:GANESHBE) Held Back By Insufficient Growth Even After Shares Climb 29%Ganesh Benzoplast Limited ( NSE:GANESHBE ) shares have continued their recent momentum with a 29% gain in the last...お知らせ • Feb 02Ganesh Benzoplast Limited to Report Q3, 2024 Results on Feb 12, 2024Ganesh Benzoplast Limited announced that they will report Q3, 2024 results on Feb 12, 2024Valuation Update With 7 Day Price Move • Jan 30Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹199, the stock trades at a trailing P/E ratio of 23.2x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 41% over the past year.お知らせ • Jan 29Ganesh Benzoplast Limited announced that it expects to receive INR 324 million in fundingGanesh Benzoplast Limited announced a private placement of 2,000,000 common shares at a price of INR 162 per share for gross proceeds of INR 324,000,000 on January 29, 2024. The transaction will include participation from new individual investor Anil Kumar Goel. The company will issue shares on preferential basis. The transaction has been approved by the board of directors of the company. The transaction still needs to be approved at the extra ordinary general meeting of the company to be held on February 21, 2024.お知らせ • Jan 12Ganesh Benzoplast Limited announced that it has received INR 303.5 million in funding from Malabar Investments, LLC, Susram Financial Services & Realty Private LimitedOn January 12, 2024, Ganesh Benzoplast Limited closed the transaction.分析記事 • Dec 14Here's Why We Think Ganesh Benzoplast (NSE:GANESHBE) Is Well Worth WatchingThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...お知らせ • Dec 05Ganesh Benzoplast Limited announced that it expects to receive INR 303.5 million in funding from Malabar Investments, LLC, Susram Financial Services & Realty Private LimitedGanesh Benzoplast Limited announced a private placement of up to 17,00,000 equity shares at a price of INR 160 per share (including premium of INR 159 per share) of face value INR 1 per share for gross proceeds of INR 272,000,000 and 1,80,000 equity shares at a price of INR 175 per share(including premium of INR 159 per share) for gross proceeds of INR 31,500,000 for aggregate proceeds of INR 303,500,000 on December 5, 2023. The transaction include participation from new investors, Malabar India Fund Limited and Susram Financial Services and Realty Private Limited. The issuance is made on Preferential Issue in accordance with Chapter V of the SEBI ICDR Regulations and other applicable law and the Securities & Exchange Board of India. Malabar India Fund Limited will subscribe for 17,00,000 shares and Susram Financial Services and Realty Private Limited will subscribe for 1,80,000 shares.Reported Earnings • Nov 08Second quarter 2024 earnings released: EPS: ₹2.33 (vs ₹2.17 in 2Q 2023)Second quarter 2024 results: EPS: ₹2.33 (up from ₹2.17 in 2Q 2023). Revenue: ₹1.04b (up 8.9% from 2Q 2023). Net income: ₹155.8m (up 15% from 2Q 2023). Profit margin: 15% (in line with 2Q 2023).お知らせ • Oct 28Ganesh Benzoplast Limited to Report Q2, 2024 Results on Nov 07, 2023Ganesh Benzoplast Limited announced that they will report Q2, 2024 results on Nov 07, 2023お知らせ • Sep 06Ganesh Benzoplast Limited, Annual General Meeting, Sep 29, 2023Ganesh Benzoplast Limited, Annual General Meeting, Sep 29, 2023, at 11:00 Indian Standard Time. Agenda: To consider Adoption of Audited Standalone and Consolidated Financial Statements; to discuss Re-appointment of Mr. Rishi Ramesh Pilani as Director; to discuss Ratification of the remuneration of the Cost Auditors for the Financial Year 2023-24; and to Consider and Approve Raising of Funds Through Qualified Institutional Placement.Reported Earnings • Aug 12First quarter 2024 earnings released: EPS: ₹2.37 (vs ₹1.97 in 1Q 2023)First quarter 2024 results: EPS: ₹2.37 (up from ₹1.97 in 1Q 2023). Revenue: ₹1.25b (up 36% from 1Q 2023). Net income: ₹154.9m (up 26% from 1Q 2023). Profit margin: 12% (down from 13% in 1Q 2023). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • Aug 11Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹175, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 35% over the past year.分析記事 • Aug 10Capital Allocation Trends At Ganesh Benzoplast (NSE:GANESHBE) Aren't IdealIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...お知らせ • Aug 04Ganesh Benzoplast Limited to Report Q1, 2024 Results on Aug 11, 2023Ganesh Benzoplast Limited announced that they will report Q1, 2024 results on Aug 11, 2023Reported Earnings • May 27Full year 2023 earnings released: EPS: ₹8.73 (vs ₹5.24 in FY 2022)Full year 2023 results: EPS: ₹8.73 (up from ₹5.24 in FY 2022). Revenue: ₹4.29b (up 20% from FY 2022). Net income: ₹550.8m (up 69% from FY 2022). Profit margin: 13% (up from 9.1% in FY 2022). The increase in margin was driven by higher revenue.お知らせ • May 19Ganesh Benzoplast Limited to Report Q4, 2023 Results on May 25, 2023Ganesh Benzoplast Limited announced that they will report Q4, 2023 results on May 25, 2023分析記事 • Feb 15We Ran A Stock Scan For Earnings Growth And Ganesh Benzoplast (NSE:GANESHBE) Passed With EaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹168, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 74% over the past year.Reported Earnings • Feb 08Third quarter 2023 earnings released: EPS: ₹2.33 (vs ₹1.69 in 3Q 2022)Third quarter 2023 results: EPS: ₹2.33 (up from ₹1.69 in 3Q 2022). Revenue: ₹1.01b (down 1.0% from 3Q 2022). Net income: ₹145.1m (up 38% from 3Q 2022). Profit margin: 14% (up from 10% in 3Q 2022). The increase in margin was driven by lower expenses.お知らせ • Feb 01Ganesh Benzoplast Limited to Report Q3, 2023 Results on Feb 07, 2023Ganesh Benzoplast Limited announced that they will report Q3, 2023 results on Feb 07, 2023Reported Earnings • Nov 05Second quarter 2023 earnings released: EPS: ₹2.17 (vs ₹0.69 in 2Q 2022)Second quarter 2023 results: EPS: ₹2.17 (up from ₹0.69 in 2Q 2022). Revenue: ₹990.5m (up 21% from 2Q 2022). Net income: ₹135.1m (up 215% from 2Q 2022). Profit margin: 14% (up from 5.3% in 2Q 2022). The increase in margin was driven by higher revenue.Recent Insider Transactions • Oct 01Chairman & MD recently bought ₹7.5m worth of stockOn the 29th of September, Rishi Pilani bought around 60k shares on-market at roughly ₹126 per share. This transaction amounted to 3.8% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Rishi's only on-market trade for the last 12 months.Reported Earnings • Aug 05First quarter 2023 earnings released: EPS: ₹1.97 (vs ₹1.50 in 1Q 2022)First quarter 2023 results: EPS: ₹1.97 (up from ₹1.50 in 1Q 2022). Revenue: ₹934.2m (up 19% from 1Q 2022). Net income: ₹123.0m (up 32% from 1Q 2022). Profit margin: 13% (up from 12% in 1Q 2022). The increase in margin was driven by higher revenue.分析記事 • Jul 09There's Reason For Concern Over Ganesh Benzoplast Limited's (NSE:GANESHBE) PriceWith a price-to-earnings (or "P/E") ratio of 25.2x Ganesh Benzoplast Limited ( NSE:GANESHBE ) may be sending bearish...Reported Earnings • May 30Full year 2022 earnings released: EPS: ₹5.24 (vs ₹3.92 in FY 2021)Full year 2022 results: EPS: ₹5.24 (up from ₹3.92 in FY 2021). Revenue: ₹3.61b (up 33% from FY 2021). Net income: ₹326.9m (up 49% from FY 2021). Profit margin: 9.1% (up from 8.1% in FY 2021). The increase in margin was driven by higher revenue.Buying Opportunity • May 25Now 20% undervaluedOver the last 90 days, the stock is up 33%. The fair value is estimated to be ₹145, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 42%.Valuation Update With 7 Day Price Move • May 20Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹125, the stock trades at a trailing P/E ratio of 63.5x. Average trailing P/E is 18x in the Chemicals industry in India.Buying Opportunity • May 09Now 21% undervaluedOver the last 90 days, the stock is up 18%. The fair value is estimated to be ₹147, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 42%.Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹128, the stock trades at a trailing P/E ratio of 72.4x. Average trailing P/E is 20x in the Chemicals industry in India.Reported Earnings • Feb 15Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.69 (down from ₹1.92 in 3Q 2021). Revenue: ₹1.03b (up 54% from 3Q 2021). Net income: ₹105.2m (down 5.7% from 3Q 2021). Profit margin: 10% (down from 17% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates.Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 26% share price gain to ₹98.10, the stock trades at a trailing P/E ratio of 47.9x. Average trailing P/E is 18x in the Chemicals industry in India.分析記事 • Nov 20We Think You Can Look Beyond Ganesh Benzoplast's (NSE:GANESHBE) Lackluster EarningsThe market for Ganesh Benzoplast Limited's ( NSE:GANESHBE ) shares didn't move much after it posted weak earnings...Reported Earnings • Nov 16Second quarter 2022 earnings released: EPS ₹0.69 (vs ₹1.84 in 2Q 2021)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹825.1m (up 52% from 2Q 2021). Net income: ₹43.0m (down 55% from 2Q 2021). Profit margin: 5.2% (down from 18% in 2Q 2021). The decrease in margin was driven by higher expenses. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Ganesh Benzoplast は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測NSEI:GANESHBE - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20264,114733150793N/A12/31/20253,999449N/AN/AN/A9/30/20253,838471328717N/A6/30/20253,824398N/AN/AN/A3/31/20253,743381159549N/A12/31/20244,206656N/AN/AN/A9/30/20244,376633-137410N/A6/30/20244,427624N/AN/AN/A3/31/20244,7716149833N/A12/31/20234,649619N/AN/AN/A9/30/20234,577603-36680N/A6/30/20234,508583N/AN/AN/A3/31/20234,208551-35406N/A12/31/20223,823488N/AN/AN/A9/30/20223,8524496871,009N/A6/30/20223,711356N/AN/AN/A3/31/20223,575327665862N/A12/31/20213,595111N/AN/AN/A9/30/20213,242117454651N/A6/30/20212,968170N/AN/AN/A3/31/20212,704219426566N/A12/31/20202,398443N/AN/AN/A9/30/20202,340421333430N/A6/30/20202,300415N/AN/AN/A3/31/20202,467337135265N/A12/31/20192,457302N/AN/AN/A9/30/20192,326298N/A348N/A6/30/20192,338294N/AN/AN/A3/31/20192,116313N/A604N/A12/31/20181,936837N/AN/AN/A9/30/20181,924830N/AN/AN/A6/30/20181,796821N/AN/AN/A3/31/20181,692807N/A393N/A12/31/20171,544257N/AN/AN/A9/30/20171,374209N/AN/AN/A6/30/20171,206144N/AN/AN/A3/31/20171,181128N/A364N/A12/31/20161,169524N/AN/AN/A9/30/20161,151527N/AN/AN/A6/30/20161,228532N/AN/AN/A3/31/20161,196482N/A418N/A12/31/20151,28451N/AN/AN/A9/30/20151,29426N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: GANESHBEの予測収益成長が 貯蓄率 ( 6.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: GANESHBEの収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: GANESHBEの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: GANESHBEの収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: GANESHBEの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: GANESHBEの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/13 08:04終値2026/07/13 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ganesh Benzoplast Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹112, the stock trades at a trailing P/E ratio of 11x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 26% over the past three years.
分析記事 • Jun 04Ganesh Benzoplast's (NSE:GANESHBE) Earnings Are Weaker Than They SeemGanesh Benzoplast Limited ( NSE:GANESHBE ) announced strong profits, but the stock was stagnant. We did some digging...
Reported Earnings • May 28Full year 2026 earnings released: EPS: ₹10.19 (vs ₹5.29 in FY 2025)Full year 2026 results: EPS: ₹10.19 (up from ₹5.29 in FY 2025). Revenue: ₹4.37b (up 17% from FY 2025). Net income: ₹733.4m (up 93% from FY 2025). Profit margin: 17% (up from 10% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 14% per year.
お知らせ • May 18Ganesh Benzoplast Limited to Report Q4, 2026 Results on May 27, 2026Ganesh Benzoplast Limited announced that they will report Q4, 2026 results on May 27, 2026
Board Change • May 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. Non-Executive Independent Woman Director Amruta Thali was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Apr 10Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹92.23, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 47% over the past three years.
Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: ₹2.24 (vs ₹2.55 in 3Q 2025)Third quarter 2026 results: EPS: ₹2.24 (down from ₹2.55 in 3Q 2025). Revenue: ₹1.13b (up 27% from 3Q 2025). Net income: ₹161.5m (down 12% from 3Q 2025). Profit margin: 14% (down from 21% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹80.46, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 46% over the past three years.
Buy Or Sell Opportunity • Jan 27Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 18% to ₹70.48. The fair value is estimated to be ₹90.23, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 8.2%.
分析記事 • Nov 21Some Investors May Be Willing To Look Past Ganesh Benzoplast's (NSE:GANESHBE) Soft EarningsSoft earnings didn't appear to concern Ganesh Benzoplast Limited's ( NSE:GANESHBE ) shareholders over the last week...
Reported Earnings • Nov 19Second quarter 2026 earnings released: EPS: ₹3.30 (vs ₹2.29 in 2Q 2025)Second quarter 2026 results: EPS: ₹3.30 (up from ₹2.29 in 2Q 2025). Revenue: ₹990.0m (up 1.4% from 2Q 2025). Net income: ₹237.6m (up 44% from 2Q 2025). Profit margin: 24% (up from 17% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.
お知らせ • Sep 26Ganesh Benzoplast Limited Appoints Amruta Pankaj Thali as Independent Woman DirectorGanesh Benzoplast Limited in its Annual General Meeting held on September 25, 2025 approved to appoint Ms. Amruta Pankaj Thali (DIN:11230644) as an Independent Woman Director of the Company.
お知らせ • Sep 01+ 1 more updateGanesh Benzoplast Limited to Report Q3, 2026 Results on Feb 14, 2026Ganesh Benzoplast Limited announced that they will report Q3, 2026 results on Feb 14, 2026
Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹2.52 (vs ₹2.28 in 1Q 2025)First quarter 2026 results: EPS: ₹2.52 (up from ₹2.28 in 1Q 2025). Revenue: ₹1.01b (up 15% from 1Q 2025). Net income: ₹181.3m (up 10% from 1Q 2025). Profit margin: 18% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 10% per year, which means it is performing significantly worse than earnings.
お知らせ • Aug 11Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2025Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2025, at 11:00 Indian Standard Time.
お知らせ • Aug 04Ganesh Benzoplast Limited to Report Q1, 2026 Results on Aug 11, 2025Ganesh Benzoplast Limited announced that they will report Q1, 2026 results on Aug 11, 2025
Valuation Update With 7 Day Price Move • May 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹107, the stock trades at a trailing P/E ratio of 20.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 11% over the past three years.
Reported Earnings • May 15Full year 2025 earnings released: EPS: ₹5.29 (vs ₹9.07 in FY 2024)Full year 2025 results: EPS: ₹5.29 (down from ₹9.07 in FY 2024). Revenue: ₹3.92b (down 18% from FY 2024). Net income: ₹380.9m (down 38% from FY 2024). Profit margin: 9.7% (down from 13% in FY 2024). Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 4% per year.
お知らせ • May 10Ganesh Benzoplast Limited to Report Q4, 2025 Results on May 14, 2025Ganesh Benzoplast Limited announced that they will report Q4, 2025 results at 9:15 AM, Indian Standard Time on May 14, 2025
New Risk • Apr 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹126, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 17% over the past three years.
分析記事 • Mar 08A Piece Of The Puzzle Missing From Ganesh Benzoplast Limited's (NSE:GANESHBE) Share PriceWhen close to half the companies in India have price-to-earnings ratios (or "P/E's") above 26x, you may consider Ganesh...
Valuation Update With 7 Day Price Move • Mar 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹127, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 29% over the past three years.
Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹2.55 (vs ₹2.34 in 3Q 2024)Third quarter 2025 results: EPS: ₹2.55 (up from ₹2.34 in 3Q 2024). Revenue: ₹934.1m (down 12% from 3Q 2024). Net income: ₹183.9m (up 14% from 3Q 2024). Profit margin: 20% (up from 15% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 07Ganesh Benzoplast Limited to Report Q3, 2025 Results on Feb 12, 2025Ganesh Benzoplast Limited announced that they will report Q3, 2025 results on Feb 12, 2025
New Risk • Jan 28New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.52b (US$98.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.
分析記事 • Jan 21Some Investors May Be Worried About Ganesh Benzoplast's (NSE:GANESHBE) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹145, the stock trades at a trailing P/E ratio of 16.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 52% over the past three years.
Reported Earnings • Nov 15Second quarter 2025 earnings released: EPS: ₹2.29 (vs ₹2.33 in 2Q 2024)Second quarter 2025 results: EPS: ₹2.29. Revenue: ₹1.02b (flat on 2Q 2024). Net income: ₹164.6m (up 5.6% from 2Q 2024). Profit margin: 16% (in line with 2Q 2024).
お知らせ • Nov 09Ganesh Benzoplast Limited to Report Q2, 2025 Results on Nov 14, 2024Ganesh Benzoplast Limited announced that they will report Q2, 2025 results on Nov 14, 2024
お知らせ • Aug 13Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2024Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2024, at 11:00 Indian Standard Time.
Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: ₹2.28 (vs ₹2.37 in 1Q 2024)First quarter 2025 results: EPS: ₹2.28. Revenue: ₹912.4m (down 25% from 1Q 2024). Net income: ₹164.3m (up 6.1% from 1Q 2024). Profit margin: 18% (up from 13% in 1Q 2024). The increase in margin was driven by lower expenses.
お知らせ • Aug 03Ganesh Benzoplast Limited to Report Q1, 2025 Results on Aug 12, 2024Ganesh Benzoplast Limited announced that they will report Q1, 2025 results on Aug 12, 2024
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹160, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 4.5% over the past year.
分析記事 • Jun 07Ganesh Benzoplast (NSE:GANESHBE) Strong Profits May Be Masking Some Underlying IssuesThe market shrugged off Ganesh Benzoplast Limited's ( NSE:GANESHBE ) solid earnings report. We did some digging and...
分析記事 • Jun 05Take Care Before Diving Into The Deep End On Ganesh Benzoplast Limited (NSE:GANESHBE)With a price-to-earnings (or "P/E") ratio of 15.7x Ganesh Benzoplast Limited ( NSE:GANESHBE ) may be sending bullish...
Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹9.07 (vs ₹8.73 in FY 2023)Full year 2024 results: EPS: ₹9.07 (up from ₹8.73 in FY 2023). Revenue: ₹4.91b (up 17% from FY 2023). Net income: ₹614.4m (up 12% from FY 2023). Profit margin: 13% (in line with FY 2023).
お知らせ • May 23Ganesh Benzoplast Limited to Report Q4, 2024 Results on May 30, 2024Ganesh Benzoplast Limited announced that they will report Q4, 2024 results on May 30, 2024
お知らせ • May 08Ganesh Benzoplast Limited Announces Resignation of Raunak Pilani as Non-Executive (Non-Independent) DirectorGanesh Benzoplast Limited informed that Mr. Raunak Pilani has tendered his resignation as a non-executive (non-independent) director of the Company with effect from May 6, 2024 and the Board has accepted his resignation vide circulatory resolution passed on May 07, 2024.
お知らせ • Mar 01Ganesh Benzoplast Limited announced that it has received INR 324 million in fundingOn March 1, 2024, Ganesh Benzoplast Limited, closed the transaction.
Reported Earnings • Feb 13Third quarter 2024 earnings released: EPS: ₹2.34 (vs ₹2.33 in 3Q 2023)Third quarter 2024 results: EPS: ₹2.34 (up from ₹2.33 in 3Q 2023). Revenue: ₹1.08b (up 8.9% from 3Q 2023). Net income: ₹160.8m (up 11% from 3Q 2023). Profit margin: 15% (in line with 3Q 2023).
分析記事 • Feb 06Ganesh Benzoplast Limited (NSE:GANESHBE) Held Back By Insufficient Growth Even After Shares Climb 29%Ganesh Benzoplast Limited ( NSE:GANESHBE ) shares have continued their recent momentum with a 29% gain in the last...
お知らせ • Feb 02Ganesh Benzoplast Limited to Report Q3, 2024 Results on Feb 12, 2024Ganesh Benzoplast Limited announced that they will report Q3, 2024 results on Feb 12, 2024
Valuation Update With 7 Day Price Move • Jan 30Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹199, the stock trades at a trailing P/E ratio of 23.2x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 41% over the past year.
お知らせ • Jan 29Ganesh Benzoplast Limited announced that it expects to receive INR 324 million in fundingGanesh Benzoplast Limited announced a private placement of 2,000,000 common shares at a price of INR 162 per share for gross proceeds of INR 324,000,000 on January 29, 2024. The transaction will include participation from new individual investor Anil Kumar Goel. The company will issue shares on preferential basis. The transaction has been approved by the board of directors of the company. The transaction still needs to be approved at the extra ordinary general meeting of the company to be held on February 21, 2024.
お知らせ • Jan 12Ganesh Benzoplast Limited announced that it has received INR 303.5 million in funding from Malabar Investments, LLC, Susram Financial Services & Realty Private LimitedOn January 12, 2024, Ganesh Benzoplast Limited closed the transaction.
分析記事 • Dec 14Here's Why We Think Ganesh Benzoplast (NSE:GANESHBE) Is Well Worth WatchingThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
お知らせ • Dec 05Ganesh Benzoplast Limited announced that it expects to receive INR 303.5 million in funding from Malabar Investments, LLC, Susram Financial Services & Realty Private LimitedGanesh Benzoplast Limited announced a private placement of up to 17,00,000 equity shares at a price of INR 160 per share (including premium of INR 159 per share) of face value INR 1 per share for gross proceeds of INR 272,000,000 and 1,80,000 equity shares at a price of INR 175 per share(including premium of INR 159 per share) for gross proceeds of INR 31,500,000 for aggregate proceeds of INR 303,500,000 on December 5, 2023. The transaction include participation from new investors, Malabar India Fund Limited and Susram Financial Services and Realty Private Limited. The issuance is made on Preferential Issue in accordance with Chapter V of the SEBI ICDR Regulations and other applicable law and the Securities & Exchange Board of India. Malabar India Fund Limited will subscribe for 17,00,000 shares and Susram Financial Services and Realty Private Limited will subscribe for 1,80,000 shares.
Reported Earnings • Nov 08Second quarter 2024 earnings released: EPS: ₹2.33 (vs ₹2.17 in 2Q 2023)Second quarter 2024 results: EPS: ₹2.33 (up from ₹2.17 in 2Q 2023). Revenue: ₹1.04b (up 8.9% from 2Q 2023). Net income: ₹155.8m (up 15% from 2Q 2023). Profit margin: 15% (in line with 2Q 2023).
お知らせ • Oct 28Ganesh Benzoplast Limited to Report Q2, 2024 Results on Nov 07, 2023Ganesh Benzoplast Limited announced that they will report Q2, 2024 results on Nov 07, 2023
お知らせ • Sep 06Ganesh Benzoplast Limited, Annual General Meeting, Sep 29, 2023Ganesh Benzoplast Limited, Annual General Meeting, Sep 29, 2023, at 11:00 Indian Standard Time. Agenda: To consider Adoption of Audited Standalone and Consolidated Financial Statements; to discuss Re-appointment of Mr. Rishi Ramesh Pilani as Director; to discuss Ratification of the remuneration of the Cost Auditors for the Financial Year 2023-24; and to Consider and Approve Raising of Funds Through Qualified Institutional Placement.
Reported Earnings • Aug 12First quarter 2024 earnings released: EPS: ₹2.37 (vs ₹1.97 in 1Q 2023)First quarter 2024 results: EPS: ₹2.37 (up from ₹1.97 in 1Q 2023). Revenue: ₹1.25b (up 36% from 1Q 2023). Net income: ₹154.9m (up 26% from 1Q 2023). Profit margin: 12% (down from 13% in 1Q 2023). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • Aug 11Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹175, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 35% over the past year.
分析記事 • Aug 10Capital Allocation Trends At Ganesh Benzoplast (NSE:GANESHBE) Aren't IdealIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
お知らせ • Aug 04Ganesh Benzoplast Limited to Report Q1, 2024 Results on Aug 11, 2023Ganesh Benzoplast Limited announced that they will report Q1, 2024 results on Aug 11, 2023
Reported Earnings • May 27Full year 2023 earnings released: EPS: ₹8.73 (vs ₹5.24 in FY 2022)Full year 2023 results: EPS: ₹8.73 (up from ₹5.24 in FY 2022). Revenue: ₹4.29b (up 20% from FY 2022). Net income: ₹550.8m (up 69% from FY 2022). Profit margin: 13% (up from 9.1% in FY 2022). The increase in margin was driven by higher revenue.
お知らせ • May 19Ganesh Benzoplast Limited to Report Q4, 2023 Results on May 25, 2023Ganesh Benzoplast Limited announced that they will report Q4, 2023 results on May 25, 2023
分析記事 • Feb 15We Ran A Stock Scan For Earnings Growth And Ganesh Benzoplast (NSE:GANESHBE) Passed With EaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹168, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 74% over the past year.
Reported Earnings • Feb 08Third quarter 2023 earnings released: EPS: ₹2.33 (vs ₹1.69 in 3Q 2022)Third quarter 2023 results: EPS: ₹2.33 (up from ₹1.69 in 3Q 2022). Revenue: ₹1.01b (down 1.0% from 3Q 2022). Net income: ₹145.1m (up 38% from 3Q 2022). Profit margin: 14% (up from 10% in 3Q 2022). The increase in margin was driven by lower expenses.
お知らせ • Feb 01Ganesh Benzoplast Limited to Report Q3, 2023 Results on Feb 07, 2023Ganesh Benzoplast Limited announced that they will report Q3, 2023 results on Feb 07, 2023
Reported Earnings • Nov 05Second quarter 2023 earnings released: EPS: ₹2.17 (vs ₹0.69 in 2Q 2022)Second quarter 2023 results: EPS: ₹2.17 (up from ₹0.69 in 2Q 2022). Revenue: ₹990.5m (up 21% from 2Q 2022). Net income: ₹135.1m (up 215% from 2Q 2022). Profit margin: 14% (up from 5.3% in 2Q 2022). The increase in margin was driven by higher revenue.
Recent Insider Transactions • Oct 01Chairman & MD recently bought ₹7.5m worth of stockOn the 29th of September, Rishi Pilani bought around 60k shares on-market at roughly ₹126 per share. This transaction amounted to 3.8% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Rishi's only on-market trade for the last 12 months.
Reported Earnings • Aug 05First quarter 2023 earnings released: EPS: ₹1.97 (vs ₹1.50 in 1Q 2022)First quarter 2023 results: EPS: ₹1.97 (up from ₹1.50 in 1Q 2022). Revenue: ₹934.2m (up 19% from 1Q 2022). Net income: ₹123.0m (up 32% from 1Q 2022). Profit margin: 13% (up from 12% in 1Q 2022). The increase in margin was driven by higher revenue.
分析記事 • Jul 09There's Reason For Concern Over Ganesh Benzoplast Limited's (NSE:GANESHBE) PriceWith a price-to-earnings (or "P/E") ratio of 25.2x Ganesh Benzoplast Limited ( NSE:GANESHBE ) may be sending bearish...
Reported Earnings • May 30Full year 2022 earnings released: EPS: ₹5.24 (vs ₹3.92 in FY 2021)Full year 2022 results: EPS: ₹5.24 (up from ₹3.92 in FY 2021). Revenue: ₹3.61b (up 33% from FY 2021). Net income: ₹326.9m (up 49% from FY 2021). Profit margin: 9.1% (up from 8.1% in FY 2021). The increase in margin was driven by higher revenue.
Buying Opportunity • May 25Now 20% undervaluedOver the last 90 days, the stock is up 33%. The fair value is estimated to be ₹145, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 42%.
Valuation Update With 7 Day Price Move • May 20Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹125, the stock trades at a trailing P/E ratio of 63.5x. Average trailing P/E is 18x in the Chemicals industry in India.
Buying Opportunity • May 09Now 21% undervaluedOver the last 90 days, the stock is up 18%. The fair value is estimated to be ₹147, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 42%.
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹128, the stock trades at a trailing P/E ratio of 72.4x. Average trailing P/E is 20x in the Chemicals industry in India.
Reported Earnings • Feb 15Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.69 (down from ₹1.92 in 3Q 2021). Revenue: ₹1.03b (up 54% from 3Q 2021). Net income: ₹105.2m (down 5.7% from 3Q 2021). Profit margin: 10% (down from 17% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates.
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 26% share price gain to ₹98.10, the stock trades at a trailing P/E ratio of 47.9x. Average trailing P/E is 18x in the Chemicals industry in India.
分析記事 • Nov 20We Think You Can Look Beyond Ganesh Benzoplast's (NSE:GANESHBE) Lackluster EarningsThe market for Ganesh Benzoplast Limited's ( NSE:GANESHBE ) shares didn't move much after it posted weak earnings...
Reported Earnings • Nov 16Second quarter 2022 earnings released: EPS ₹0.69 (vs ₹1.84 in 2Q 2021)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹825.1m (up 52% from 2Q 2021). Net income: ₹43.0m (down 55% from 2Q 2021). Profit margin: 5.2% (down from 18% in 2Q 2021). The decrease in margin was driven by higher expenses.